Late last month the skin care ingredient maker and biotech engineering company announced their new research collaboration: an effort to develop novel actives for the
microbiome beauty movement.
Felix Biotechnology specializes in targeted antimicrobial technologies, developing biotherapeutic solutions for the heath care industry and similar relevant applications. “Leveraging the potential of our technology across a range of applications allows us to have the biggest impact possible,” says Natalie Ma, Head of Business Development at Felix Biotechnology, is a recent media release about the partnership. “And,” she adds, “we are very excited to be working with a leader in the personal care and cosmetic space like Biocogent on this project.”
The San Francisco, California – based company was founded in 2019 and works closely with researchers at both Yale University and the University of California, Berkeley to address “urgent microbial challenges in human health and beyond.”
By Deanna Utroske – 06 Jul 2021